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Abstract
Background: Depression is a common, disabling condition for which psychological treatments are recommended.
Behavioural activation has attracted increased interest in recent years. It has been over 5 years since our meta-analyses
summarised the evidence supporting and this systematic review updates those findings and examines moderators of
treatment effect.
Method: Randomised trials of behavioural activation for depression versus controls or anti-depressant medication were
identified using electronic database searches, previous reviews and reference lists. Data on symptom level and study level
moderators were extracted and analysed using meta-analysis, sub-group analysis and meta-regression respectively.
Results: Twenty six randomised controlled trials including 1524 subjects were included in this meta-analysis. A random
effects meta-analysis of symptom level post treatment showed behavioural activation to be superior to controls (SMD 2
0.74 CI 20.91 to20.56, k = 25, N = 1088) and medication (SMD20.42 CI20.83 to-0.00, k = 4, N = 283). Study quality was low
in the majority of studies and follow- up time periods short. There was no indication of publication bias and subgroup
analysis showed limited association between moderators and effect size.
Conclusions: The results in this meta-analysis support and strengthen the evidence base indicating Behavioural Activation is
an effective treatment for depression. Further high quality research with longer term follow-up is needed to strengthen the
evidence base.
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Introduction
Depression is the most common mental disorder in community
settings [1] and recent predictions state that by 2030 it will be the
leading cause of disease burden in high-income countries [2].
NICE [1] promote the use of cognitive behavioural therapy (CBT)
combining both behavioural and cognitive techniques. More
recently a meta-analysis has suggested equivalence across most
psychotherapies for depression [3]. If this is the case the idea of
parsimony, using the least complex but acceptable theoretically
derived treatment, may offer considerable benefit in terms of
stability and distribution of the chosen intervention.
Behavioural Activation (BA) may be one such parsimonious
treatment option. It uses the principles of operant conditioning
through scheduling to encourage depressed people to reconnect
with environmental positive reinforcement. Whereas more com-
plex therapies such as CBT require 1–2 years of intensive training
for therapists to acquire the wide range of competencies the
relative small set of techniques necessary for effective delivery of
BA may be possible to acquire after 5 days [4].
It has been 5 years since we conducted the searches for our
previous two meta-analyses which indicated BA offered an
effective and simple intervention in 16 and 17 randomised
controlled trials respectively [5,6]. This systematic review and
meta-analysis updates our previous work exploring the effective-
ness of BA as a psychological therapy for depression compared to
usual care as we were aware that new studies had been conducted.
In addition we explore the relationship of study level moderators
such as therapist training level, delivery mode, multi-morbidity,
number of sessions and severity with treatment effect. The review
also adds to the current evidence base by extending the review to
explore BA compared to anti-depressant medication.
Methods
Identification and Selection of Studies
We included studies identified in previous meta-analyses [5,6]
and cross referenced with on additional BA review [7]. In addition
we searched a database of 352 psychotherapy studies of
depression. This database has been used in a series of published
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meta-analysis examining depression (www.evidencebasedpsycho
therapies.org) and has been described in detail elsewhere [8]. It is
updated yearly using a systematic and comprehensive review of all
published evidence (1966 to January 2013) and included 14,164
abstracts (3,638 from pubmed, 2,824 from psycinfo, 4,682 from
embase, and 3,020 from the Cochrane Central Register of
Controlled Trials). Reference lists of identified studies and meta-
analyses were examined to ensure no studies had been missed.
Finally key researchers in BA were contacted to identify any
missed studies or studies in press.
Inclusion Criteria
We included all randomised controlled trials for adult ($16
years) patients with a primary diagnosis of depression who were
treated in community or in-patient settings with BA. BA was
defined as a behaviourally oriented time limited psychotherapeutic
intervention including key elements of self-monitoring and activity
scheduling. As BA is a relatively recent term used to describe this
intervention we also included studies of behavioural therapy for
depression if self-monitoring and activity scheduling were core
elements of the intervention. Comparators consisted of a range of
waiting list, placebo and usual care. We did not explore the
comparative effectiveness of BA with other psychotherapies as this
has been updated in other recent reviews [3,9] [9,10]. We also
explored studies where BA had been compared with antidepres-
sant medication. This comparison has been missing in previous
reviews and represents an important consideration as antidepres-
sants remain the most commonly received treatment for depres-
sion [11]. We included studies in any language to reduce the risk of
potential publication bias.
Studies excluded were those which included participants with
psychosis or bipolar disorder, substance misuse problems, cogni-
tive impairment or without depression as a primary diagnosis.
Study Level Moderators
Subgroup analyses were conducted to explore any potential
dispersion across results. We investigated the moderating effects of:
N Group/Individual therapy
N Clinical/non clinical populations (i.e. student samples)
N Recruitment setting/approach
N Baseline depression severity
N Method of depression categorisation at assessment
N Level of therapist experience (psychotherapist/psychologist
compared to specifically trained non specialist)
N Control type
N Number of sessions
N Quality of included studies.
In addition we explored the type of behavioural treatment
employed in the study and if these were associated with effect. We
examined the number of the elements currently considered core to
BA (self-monitoring, activity scheduling, functional analysis, values
assessment) included in each study as a continuous variable and if
the treatment were considered simple BA (predominantly self-
monitoring and scheduling) or complex BA (self-monitoring,
scheduling plus additional behavioural components such as
functional analysis and/or values focussed interventions). This
subgroup analysis represented an important consideration as more
complex BA studies have been excluded from recent reviews [9] as
they were deemed to represent ‘third wave CBT’. This classifi-
cation is not commonly accepted however and careful consider-
ation of the cumulative effect of intervention components would
represent useful new data relevant to this debate.
Outcome Measures
Our primary outcome measure was depression symptom level,
collected either via self-rated or via clinician-rated measures.
Where studies included multiple symptom measures, all data were
entered and the mean effect was calculated, so that each study
provided one estimate of effect.
Quality Assessment
Quality of studies was rated according to the Cochrane
Collaboration’s Tool for Assessing Risk of Bias [12]. The elements
used were;
1. Adequate generation of randomisation sequence
2. Allocation concealment
3. Blinding of assessment
4. Dealing with missing data.
Due to the difficulties of blinding participants, therapists and
other associated health professionals in psychotherapy studies, this
quality factor was excluded. Each study was scored against the
above to provide a score of between 0 and 4.
Data Extraction and Sub Group Coding
Two researchers extracted data from each trial post treatment
and where possible at follow up. Those data were checked by LW
and DE in a series of meetings. Any inconsistencies were referred
back to the original text. Missing data were requested from study
authors by email. Missing standard deviation (SD) scores were
imputed from other relevant studies where these data were not
available, with imputations tested in sensitivity analysis as per
accepted procedures [13]. Finally extracted data were reviewed in
a group meeting (DE, LW, A VS and PC) where consensus was
reached.
Meta-analyses
Effect size was calculated using the Comprehensive Meta-
analysis (version 2.2.064) [14] computer program using standard-
ised mean difference (SMD) with value ranges of small (0–0.32),
medium (0.33–0.55) and large (0.56 and above) as per standard
convention [15]. This approach allows analysis of the same
outcome (depression symptom level) using different scales by
subtracting the post-test mean of the intervention group from the
post-test mean of the control group and dividing results by the
pooled standard deviation. This provided the SMD, a consistent
scale across measures of depression symptom level in included
studies. Hedges g was reported to adjust for potential small sample
bias anticipated in this review. Where studies included two or
more measures of depression, all data were entered and the mean
effect size was calculated within the CMA program. Where studies
reported stratified results (i.e. high/low severity) these were
combined using the study as the unit of analysis in CMA to
reduce undue influence on heterogeneity. A hierarchy of reported
data was used for entry into meta-analysis, with means and
standard deviations taking priority, as these were considered the
best assessment of outcome. Where these were not reported we
used effect size data, dichotomous data or tests of significance in
that order of preference. Where studies reported dichotomous
outcomes, data were used to calculate a standardised effect size
using a logit transformation in CMA. We present pooled data with
95% confidence intervals. As we were including studies across a
A Meta-Analysis of Behavioural Therapy for Depression: An Update
PLOS ONE | www.plosone.org 2 June 2014 | Volume 9 | Issue 6 | e100100
T
a
b
le
1
.
P
ro
p
e
rt
ie
s
o
f
in
cl
u
d
e
d
st
u
d
ie
s.
S
tu
d
y
F
ir
st
A
u
th
o
r
Y
e
a
r
C
o
n
tr
o
l
T
y
p
e
B
A
C
li
n
ic
a
l
In
te
rv
ie
w
O
u
tc
o
m
e
M
e
a
su
re
L
e
v
e
l
o
f
T
h
e
ra
p
is
t
D
e
li
v
e
ry
M
o
d
e
N
o
o
f
S
e
ss
io
n
s
B
a
se
li
n
e
D
e
p
re
ss
io
n
L
e
v
e
l
P
o
p
u
la
ti
o
n
C
o
u
n
tr
y
F
o
ll
o
w
-u
p
P
e
ri
o
d
Fu
ch
s
[6
5
]
1
9
7
7
W
L
S
O
th
e
r
SR
SP
G
6
M
o
d
Se
ve
re
G
e
n
e
ra
l
U
SA
6
w
e
e
ks
Sh
aw
[6
6
]
1
9
7
7
W
L
S
O
th
e
r
C
l/
SR
SP
G
8
M
o
d
Se
ve
re
U
n
iv
e
rs
it
y
U
SA
4
w
e
e
ks
T
ay
lo
r
[6
7
]
1
9
7
7
W
L
C
O
th
e
r
SR
SP
I
6
M
o
d
Se
ve
re
U
n
iv
e
rs
it
y
C
an
ad
a
5
w
e
e
ks
M
cL
e
an
[6
8
]
1
9
7
9
P
la
ce
b
o
/
m
e
d
ic
at
io
n
S
O
th
e
r
SR
SP
I
1
0
M
o
d
Se
ve
re
G
e
n
e
ra
l
U
SA
1
2
w
e
e
ks
C
o
m
as
-D
ia
z
[6
9
]
1
9
8
1
W
L
S
O
th
e
r
C
l/
SR
SP
G
5
M
o
d
Se
ve
re
G
e
n
e
ra
l
U
SA
P
o
st
tr
e
at
m
e
n
t
R
e
h
m
[7
0
]
1
9
8
1
W
L
S
St
ru
ct
u
re
d
SR
SP
G
7
M
o
d
Se
ve
re
G
e
n
e
ra
l
U
SA
7
w
e
e
ks
M
Lo
p
e
z
[7
1
]
1
9
8
2
T
A
U
S
O
th
e
r
C
l/
SR
SP
I
1
0
M
o
d
Se
ve
re
G
e
n
e
ra
l
Sp
ai
n
P
o
st
tr
e
at
m
e
n
t/
1
2
w
e
e
ks
W
ils
o
n
[7
2
]
1
9
8
2
P
la
ce
b
o
/W
L/
m
e
d
ic
at
io
n
S
O
th
e
r
SR
SP
I
7
M
o
d
Se
ve
re
G
e
n
e
ra
l
A
u
st
ra
lia
1
w
e
e
k/
2
4
w
e
e
ks
W
ils
o
n
[7
3
]
1
9
8
3
W
L
S
O
th
e
r
C
l/
SR
SP
I
8
M
o
d
Se
ve
re
G
e
n
e
ra
l
A
u
st
ra
lia
8
w
e
e
ks
Sk
in
n
e
r
[7
4
]
1
9
8
4
W
L
S
O
th
e
r
SR
SP
I
5
M
o
d
Se
ve
re
G
e
n
e
ra
l
U
SA
5
w
e
e
ks
T
h
o
m
p
so
n
[7
5
]
1
9
8
4
W
L
S
St
ru
ct
u
re
d
C
l/
SR
SP
I
6
M
o
d
Se
ve
re
O
ld
e
r
U
SA
6
w
e
e
ks
T
h
o
m
p
so
n
[7
6
]
1
9
8
7
W
L
S
St
ru
ct
u
re
d
C
l/
SR
SP
I
1
6
M
o
d
Se
ve
re
O
ld
e
r
U
SA
6
w
e
e
ks
Lo
ve
tt
[7
7
]
1
9
8
8
W
L
S
O
th
e
r
C
l
SP
G
1
0
M
ild
M
o
d
O
ld
e
r
U
SA
1
0
w
e
e
ks
V
an
d
e
n
H
o
u
t
[7
8
]
1
9
9
5
T
A
U
S
St
ru
ct
u
re
d
SR
SP
G
1
2
M
o
d
Se
ve
re
G
e
n
e
ra
l
N
e
th
e
rl
an
d
P
o
st
tr
e
at
m
e
n
t/
1
2
w
e
e
ks
R
o
kk
e
[7
9
]
1
9
9
9
W
L
S
St
ru
ct
u
re
d
C
l
SP
I
1
0
M
ild
M
o
d
O
ld
e
r
U
SA
1
0
w
e
e
ks
G
al
la
g
h
e
r
[8
0
]
2
0
0
0
W
L
S
St
ru
ct
u
re
d
C
l
SP
G
1
0
M
ild
M
o
d
G
e
n
e
ra
l
U
SA
1
2
w
e
e
ks
St
u
d
y
Fi
rs
t
A
u
th
o
r
Y
e
ar
C
o
n
tr
o
l
T
yp
e
B
A
C
lin
ic
al
In
te
rv
ie
w
O
u
tc
o
m
e
M
e
as
u
re
Le
ve
l
o
f
T
h
e
ra
p
is
t
D
e
liv
e
ry
M
o
d
e
N
o
o
f
Se
ss
io
n
s
B
as
e
lin
e
D
e
p
re
ss
io
n
Le
ve
l
P
o
p
u
la
ti
o
n
C
o
u
n
tr
y
Fo
llo
w
-u
p
P
e
ri
o
d
C
u
lle
n
[8
1
]
2
0
0
6
W
L
C
St
ru
ct
u
re
d
SR
SP
I
1
0
M
o
d
Se
ve
re
G
e
n
e
ra
l
U
SA
P
o
st
tr
e
at
m
e
n
t/
1
2
w
e
e
ks
D
im
iji
an
[8
2
]
2
0
0
6
P
la
ce
b
o
/
m
e
d
ic
at
io
n
C
St
ru
ct
u
re
d
C
l/
Se
lf
R
SP
I
1
6
M
ild
M
o
d
/M
o
d
Se
ve
re
G
e
n
e
ra
l
U
SA
8
w
e
e
ks
G
aw
ry
si
ak
[8
3
]
2
0
0
9
W
L
C
O
th
e
r
SR
SP
I
1
M
o
d
Se
ve
re
U
n
iv
e
rs
it
y
U
SA
2
w
e
e
ks
M
it
ch
e
ll
[8
4
]
2
0
0
9
T
A
U
S
St
ru
ct
u
re
d
C
l
N
S
I
9
M
o
d
Se
ve
re
G
e
n
e
ra
l
U
SA
9
w
e
e
ks
/1
2
m
o
n
th
s/
2
4
m
o
n
th
Ek
e
rs
[8
5
]
2
0
1
1
T
A
U
C
St
ru
ct
u
re
d
SR
N
S
I
1
2
M
o
d
Se
ve
re
G
e
n
e
ra
l
U
K
1
2
w
e
e
ks
A
rm
e
n
to
[8
6
]
2
0
1
2
P
la
ce
b
o
C
St
ru
ct
u
re
d
SR
SP
G
1
M
ild
M
o
d
U
n
iv
e
rs
it
y
U
SA
4
w
e
e
ks
C
ar
lb
ri
n
g
[8
7
]
2
0
1
3
W
L
C
St
ru
ct
u
re
d
SR
SP
SH
7
M
o
d
Se
ve
re
G
e
n
e
ra
l
Sw
e
d
e
n
8
w
e
e
ks
A Meta-Analysis of Behavioural Therapy for Depression: An Update
PLOS ONE | www.plosone.org 3 June 2014 | Volume 9 | Issue 6 | e100100
long time span and number of control conditions we anticipated
heterogeneity, and hence calculated effect sizes using a random
effects model [16]. The random effects model takes into account
both within- and between-study variance. Statistical heterogeneity
was examined using the I2statistic for statistical variation across
studies [17]. The I2statistic provides a measure of the proportion of
dispersion of effects across studies that reflect real differences
rather than random error. Benchmark values of 25%, 50% and
75% reflect low, moderate and high heterogeneity respectively and
we report with 95% confidence intervals. The I2statistic does not
include a test of significance so we calculated the Q statistic and
report P values associated with that. In addition, SMDs were
translated into number needed to treat (NNT) using accepted
formulae [18] to ease interpretation of results from a clinical
perspective. NNT indicates the number of patients requiring
intervention to achieve one additional positive outcome over a
comparator.
Subgroup analyses were conducting using a mixed effects model
[14,19]. This process pools results within groups using a random
effects model, and tests for significant difference between
subgroups using a fixed effects model. Meta -regression was used
for exploration of the moderating impact of continuous variables
on effect size indicated by a Z-value and associated p value
[14,19]. We examined the impact of our a priori moderators and
type of control condition on effect size. Publication bias was
assessed through visual inspection of a funnel plot graph on the
primary outcome (post-treatment depression score) for asymmetry.
This is an accepted approach, but is subject to inconsistency, with
sufficient studies ($10) being required to differentiate real from
spurious asymmetry [20]. In order to counter this problem, an
Egger weighted regression test [21] was calculated to quantify
potential publication bias, and the trim and fill procedure [14,19]
used to estimate effect size after any such bias was taken into
account.
Results
After examination 44 of the identified studies were excluded.
The reasons for exclusion of these 44 studies were as follows: three
studies did not randomise participants adequately [22–24], eleven
only included active intervention comparisons (therefore no
control/active control) [25–35], five studies reported excessively
high attrition rates ($50%) or incomplete outcome data [36–40]
In two studies depression was not reported as the primary
diagnosis [41,42], three studies were excluded as participants
suffered from primary substance misuse problems (drug/alco-
hol)[43–45]; one study was excluded as participants had a
cognitive impairment [46]. Eight studies were excluded due to
cognitive or counselling elements being included in the BA [47–
54] and five studies were excluded as the symptom level measure
used were not depression specific (e.g. BADS/HADS) [55–58].
Three studies were dissertation abstracts or papers that were not
available for download in the UK [59–61]; one study was excluded
as it was a pilot evaluation of culturally adapted behavioural
activation [62] and finally two studies was excluded as they were
doctoral dissertation versions of a later included published papers
[63,64].
Study details are presented in table 1 and inclusion flow chart
figure 1.
Description of Studies
Twenty five studies compared BA with control treatments with
a total of 1088 subjects (BA condition N=547; Control condition
N=541) matched the inclusion criteria and were included in the
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current meta-analysis. A summary of the characteristics of the
included studies are presented in Table 1. Sixteen studies focused
on the general population, four focused on university students,
four focused on older adults, and one on women with post-natal
depression. Nineteen studies were set in specialist mental health
services, four in primary care or physical health care and two were
web based. Sixteen studies involved participants contacting the
research team, four studies used screening procedures, three
studies used referral and two a mixed approach. Nine studies
incorporated complex BA as an intervention and the remaining 16
incorporated simple BA. Twelve studies used a structured clinical
interview whereas the remaining 13 used other unstructured
forms. Ten studies used both clinician and self-rated measures of
depression, 11 used only self-rated measures, and four used
clinician rated measures. Treatment as usual was used for the
control type in six of the studies, waiting list control was used in 15
of the studies, and a psychological placebo intervention was used
in three of the studies. One study used both a waiting list and a
placebo as control type. The level of therapist varied from
specialist in 22 of the studies, and non-specialist in the remaining
three. The delivery mode of the therapy was in an individual
format in 15 of the studies, a group format in eight and self-help in
the remaining two. Baseline depression scores were moderate to
severe for 20 of the studies and mild to moderate for four. One
study included both mild-moderate and moderate to severe scores.
Number of sessions varied between one and 16. Seventeen studies
were conducted in the United States, two in Australia, one in
Canada, one in Sweden, one in the Netherlands, one in Spain, and
two in the UK.
One additional study [89] and three studies also included in the
BA vs. control comparison [68,72,82,89] were included in the BA
vs. Medication meta-analysis (BA condition n= 130; anti-depres-
sant medication n= 153). Two studies used SSRI medication ad
complex BA [82,89] with the other two using tri-cyclic medication
ad simple BA. Further details of these studies can be seen in table 1.
We generally classed studies as low quality with only seven
reporting three or more of our quality standards (see table 2).
Meta-Analysis BA vs. Control Interventions
BA for depression was compared to controls in 25 studies
including 31 comparisons and 1088 participants. The SMD (g) at
post treatment was 20.74 (95% CI 20.91 to 20.56 p,0.001
NNT 2.5), representing a large effect size (fig. 2). Sensitivity
analysis replacing mid-range imputed standard deviations with
lowest and highest observed values had minimal influence on
results (g=20.89, 95% CI21.14 to20.64 and g=20.67 95% CI
20.83 to 20.50 respectively). There was moderate between-study
heterogeneity of treatment effects beyond what would be expected
due to sampling error (Q 51.64 p 0.008 I2 41.91%). Subgroup
analysis was used to explore this dispersion further. We found a
significant association with effect size and subgroup in two areas,
control type and baseline depression severity. All other subgroup
comparisons identified similar SMD across groups (see table 3).
Study quality was sub optimal in all but six studies, subgroup
analysis indicated no significant relationship between study quality
and effect size. The SMD (g) of comparisons in low quality studies
at post treatment was 20.77 and in high quality studies 20.67
with similar levels of statistical heterogeneity (see table 3). The
median number of clinical sessions with a therapist was eight
Figure 1. Flowchart of study inclusion.
doi:10.1371/journal.pone.0100100.g001
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(range one to 16). Meta-regression using session number as a
mediator resulted in a slope of 0.03 (95% CI 20.01 to 0.06, Q total
51.92 p= 0.01, Q session number 2.08 p= 0.15), indicating no
significant influence on effect size. Meta-regression using BA
components as a mediator resulted in a non-significant slope of
0.04 (95% CI 20.11 to 0.20, Q total 51.64 p= 0.01, Q session number
0.32 p= 0.57), indicating minimal influence on effect size.
Inspection of the funnel plot indicated no evidence of
publication bias. Trim and fill procedures supported this
observation, suggesting no change in effect sizes when imputation
for potential missing data was undertaken. Egger’s test indicated a
symmetrical distribution (intercept 20.92 95% CI 22.26 to 0.43
p= 0.17). In 13 (50%) studies with the largest sample sizes an
SMD 20.62 (20.78 to 20.47) was observed indicating only a
limited influence of small studies on the overall estimated effect.
Five studies including eight comparisons and 273 participants
provided follow up data between 6–9 months. The SMD (g) at
follow up was 20.35 (95% CI 20.59 to 20.11 p,0.001 NNT
5.1), representing a medium effect size. There was no evidence of
between-study heterogeneity of treatment effects (Q 5.12, p 0.66,
I2 0%).
Meta-analysis BA vs. Antidepressant Medication
BA for depression was compared to antidepressant medication
in four studies including 283 participants. The SMD (g) at post
treatment was 20.42 (95% CI 20.83 to 20.00 p 0.05 NNT 4.27),
representing a moderate effect size in favour of BA (see fig. 3).
There was moderate between-study heterogeneity of treatment
effects beyond what would be expected due to sampling error (Q
8.34 p 0.04, I2 64.02%). Two studies used SSRI [82,89] with two
studies tricyclic antidepressant medication [68,72] with no
apparent association between drug type and effect size (see
table 2). There were insufficient studies to allow further
exploration of subgroups or potential publication bias. We
conducted sensitivity analysis on study quality by removing the
two low quality studies from the analysis [68,72] resulting in a non-
significant effect size in favour of BA of 20.38 (95% CI 21.23 to
0.47 p 0.38).
Discussion
In this updated review we found that behavioural activation for
depression is clinically effective. With the increased interest in BA
over previous years such an update was needed as our previous
Table 2. Study quality assessment.
First Author Year Study Quality Elements (+/2)
Q1 Q2 Q3 Q4
Fuchs [65] 1977 2 2 2 2
Shaw [66] 1977 2 2 + 2
Taylor [67] 1977 2 2 2 2
Mclean [68] 1979 2 2 + 2
Comas-Diaz [69] 1981 2 2 2 2
Rehm [70] 1981 2 2 + 2
Maldonado2Lopez [71] 1982 2 2 2 2
Wilson [72] 1982 2 2 2 2
Wilson [73] 1983 2 2 2 2
Skinner [74] 1984 2 2 2 2
Thompson [75] 1984 2 2 2 2
Thompson [76] 1987 2 2 2 2
Lovett [77] 1988 2 2 2 2
Van den Hout [78] 1995 2 2 2 2
Rokke [79] 1999 2 2 2 +
Gallagher-Thompson [80] 2000 2 2 2 2
Cullen [81] 2006 2 2 2 +
Dimijian [82] 2006 + 2 + +
Gawrysiak [83] 2009 2 2 2 2
Mitchell [84] 2009 + + + +
Ekers [85] 2011 + + + +
Armento [86] 2012 2 2 2 2
Carlbring [87] 2013 + + + +
Kanter [88] 2013 + + + +
Moradveisi [89] 2013 + + + +
O’Mahen [90] 2013 + + 2 +
Q1: Adequate generation of randomisation sequence; Q2: Allocation concealment; Q3: Blinding of assessment; Q4: dealing with missing data.
doi:10.1371/journal.pone.0100100.t002
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reviews were conducted over 5 years ago [5,6]. This current
review includes 26 studies which is a clear increase over the 16/17
included in those previous reviews. In addition this current update
addresses some of the gaps identified in those reviews (BA vs.
medication). We found BA to be superior to controls across 31
comparisons in 25 studies and small but significant short term
superiority to antidepressant medication.
We found a large effect size across studies (g20.74), similar to
those found in our previous reviews (d =20.70 and 20.87
respectively) whilst including considerably more comparisons and
participants. The confidence intervals around these results have
decreased slightly from previous reviews. However it is of note that
generally studies were small, of low quality and results were short
term. This is not surprising as psychotherapy studies often include
small sample sizes and participants in control arms were also often
offered active treatment after a delay period. We have, however,
been able to include sufficient studies in our meta-analysis
providing a good overview of findings and the ability to explore
the moderate heterogeneity found by subgroup analysis.
We explored the association between the types of participant
recruited and the effect size of the intervention in three subgroup
comparisons. We could find no difference in effect between
recruitment groups (general adult, older adult, student, post natal)
nor if a diagnostic interview had been used in studies, although
statistical power to detect differences between subgroups was low.
We did however find a larger effect size in studies that had higher
baseline depression severity. In addition the setting within which
recruitment was conducted and the processes used to identify
participants did not moderate the effect size of BA.
Intervention factors appeared to have no association with effect
size. Most studies used individual face to face or group therapy
with two studies using self-help based BA with a comparable effect
size across delivery modes. One of the potential benefits of BA that
has been discussed for some time has been the potential for
dissemination due to the relative simplicity of the treatment [29].
In our previous meta-analysis we found no evidence to support this
claim, however in this review three studies did include non-
specialist therapists. The effect sizes in these studies were large and
consistent, and no different from those seen in studies using
specialists. Despite being few in number, studies using non-
specialists were well conducted and no heterogeneity was observed
between them, providing the first evidence supporting the
dissemination of BA outside expert delivery. In addition we
considered the complexity of BA, observations that are timely as
recently some reviewers have sought to reclassify complex BA
approaches as a third wave CBT distinct from core BA elements
[9]. We found no association between effect size and the level of
complexity of the BA used in studies where functional analysis and
other ‘complex’ elements were added; as such the re-branding of a
sub set of BA studies would appear premature. In addition to the
complexity we explored the number of sessions via meta-
regression. The median number of sessions in included studies
was eight, there was no evidence that the number of sessions was
associated with effect size.
BA was compared to a waiting list control in 20 comparisons,
usual care in six and a placebo intervention in five. A significant
effect was found indicating that the effect size in those studies using
a placebo intervention (attention control/relaxation/drug placebo)
as control were smaller than those using waiting list or usual care.
Figure 2. Behavioural Activation vs. control post treatment (ordered by effect size high to low).
doi:10.1371/journal.pone.0100100.g002
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In summary we found no evidence that population, approach to
clinical diagnosis, number of sessions or therapist qualification/
complexity of BA had any association with outcome. We did
however observe a relationship between baseline severity and the
type of control group with outcome. The degree to which this
explains the overall heterogeneity observed in our main post
treatment results is unclear but the findings provide some analysis
of that finding.
Previous reviews have not included a meta-analysis of BA vs.
medication due to the limitation of available evidence, NICE [1]
reported one study indicating no difference between groups. In
this review we were able to include four studies and found a small
but significant difference at post treatment in favour of BA. It is of
note, however, when low quality studies were removed from the
analysis these differences disappeared suggesting caution when
interpreting results. There appeared to be no difference between
types of anti-depressant, but again both studies that use tri cyclic
medication were of low quality limiting reliability of findings.
A number of limitations exist to this review.Whilst wewere able to
include a reasonable number of studies it is of note that many were
small and of poor quality. The median sample size in the BA arms
were11and16 forcontrols andmedicationgroups,with rangesof4 to
56 and 9 to 50 respectively. This links directly to the quality of the
studies, there were a significant amount of older studies which
generally were not subject to the same level of quality standards as
those conducted in recent years.Rather than exclude such studieswe
chose to include them and deal with quality issues via subgroup and
sensitivity analysis.Whilst study qualitywasnot associatedwith effect
size when BA was compared to controls it is of note that only seven
studies of the 26 included met three or more commonly accepted
standards forRCTs.Studyquality appears tobe improvingover time
with those seven studies being generally themost recently conducted
however the publication of further high quality studies is needed to
improve confidence in these findings. In contrast when poor quality
studies were excluded in the BA comparison to medication analysis,
the significance of the effect in favour of BA disappeared. This
suggests that results found in this comparison must be viewed with
caution due to the limited numbers of studies and participants
included in the review.We focusmainly ondepressionoutcomespost
treatmentasonly five studies include followupdatabeyond6months.
Some other studies do report longer term follow up for BA that
appears promising [38] however comparisons are with other active
therapeutic interventions, not control participants, and as such did
not meet our inclusion criteria. Our analysis of follow up data vs.
control interventions indicates a medium effect size between six and
nine months however further research is required examining the
longer termbenefits of BA. Seventeen of the 26 included studieswere
conducted in the United States (US) and whilst we could observe no
difference between the effect sizes between those inside and outside
the US this should be considered in the interpretation of results. The
keyargument linkedtothedisseminationofBAis thedurabilitywithin
wider dissemination and whilst we were able to conduct the first
exploration of this in meta-analysis from a clinical perspective the
linked question of cost utility requires more research.
Despite limitations, our updated meta-analysis provides evi-
dence that supports BA as an effective treatment for depression
with outcomes at least as effective as anti-depressant medication.
We have found early indications supporting the implementation of
the intervention beyond the traditional psychotherapy workforce.
Further, individually fully powered and high quality trials are
needed to test BA in terms of low cost implementation and the cost
effectiveness this may offer. We are aware of at least one large
scale randomised controlled trial currently underway to answer
these questions [91].
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